Search results for "Depression"

showing 10 items of 1778 documents

Sleep Disturbances in Patients with Advanced Cancer in Different Palliative Care Settings.

2015

Abstract Context Information regarding sleep disturbances in the population with advanced cancer is meager. Objectives To assess the prevalence of sleep disturbances and possible correlations with associated factors in a large number of patients with advanced cancer admitted to different palliative care settings. Methods This was an observational study performed in different settings of palliative care. A consecutive sample of patients with advanced cancer was prospectively assessed for a period of six months. Epidemiological and clinical data, treatments received in the last month, Karnofsky status, Edmonton Symptom Assessment System scores, and concomitant medical treatment were recorded.…

medicine.medical_specialtyPediatricsPalliative careCross-sectional studyinsomniaPopulationSleep disturbanceadvanced cancer; insomnia; palliative care; Sleep disturbances; Anesthesiology and Pain Medicine; Neurology (clinical); Nursing (all)2901 Nursing (miscellaneous)Sleep Wake DisordersHospital Anxiety and Depression ScalemedicineInsomniaadvanced cancerAthens insomnia scaleeducationProspective cohort studyGeneral NursingNursing (all)2901 Nursing (miscellaneous)education.field_of_studypalliative carebusiness.industrySleep disturbancesAnesthesiology and Pain MedicinePhysical therapyNeurology (clinical)medicine.symptombusiness
researchProduct

W05-01 - Rationale and Design of an RCT Comparing “EMC-Strategy” with TAU in Patients with Major Depression - the EMC Trial

2010

IntroductionFor Major Depression, current guidelines recommend treatment durations of 3-8 weeks until optimisation in case of insufficient outcome. Many retrospective studies indicate that improvement (HAMD-17 decrease ≥20%) occurs usually within 10-14 days and that non-improvement after 14 days of treatment is highly predictive for poor clinical outcome.MethodsIn level 1 of the EMC trial, non-improvers after 14 days of antidepressant treatment will be randomised to “early medication change” (EMC) strategy or treatment according to current guidelines (TAU). EMC schedules treatment optimisations on day 15 and day 29 in case of non-improvement. TAU schedules a medication change after 28 days …

medicine.medical_specialtyPediatricsbusiness.industryRetrospective cohort studylaw.inventionMedication changeClinical PracticePsychiatry and Mental healthRandomized controlled triallawMedicineIn patientbusinessPsychiatryDepression (differential diagnoses)European Psychiatry
researchProduct

Temporal profile of gene induction after venous ischemia accompanied by spreading depression as compared to spreading depression alone

2002

Abstract The occlusion of two adjacent cortical veins is followed by a widespread reduction of rCBF and the occurrence of small infarcts, which become larger if spreading depression (SD) occurs. The model appears to be useful for studying penumbra pathophysiology. Here, the time course of gene expression in the penumbra was compared to those induced by the SD alone. In an experiment involving rats, an occlusion of two cortical veins was induced by i.v. rose bengal and fiberoptic illumination. Ten SDs were induced at 7-min intervals. Changes of the gene expression after 2, 8, 24 and 72 h were analysed for 13 genes by RT-PCR. The housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAP…

medicine.medical_specialtyPenumbraIschemiaGeneral MedicineAnatomyBiologymedicine.diseasePathophysiologyHousekeeping geneEndocrinologyCyclin D1Cortical spreading depressionInternal medicineOcclusionGene expressionmedicineInternational Congress Series
researchProduct

Depression mediates physical activity readiness and physical activity in patients with heart failure.

2021

Aims Although physical activity (PA) and exercise are essential for patients with heart failure (HF), adherence to the recommended guidelines is low. Not much is known about the mediating effect of HF patients mental state with their readiness for PA and reported activity levels. The purpose of this study is to investigate the mediatory effect of depression on PA readiness (physical limitation and psychological readiness) and self-reported PA in patients with HF. Methods and results In this cross-sectional study, 163 New York Heart Association Class I and II HF patients, during their clinic visit, reported on their physical limitation (PAR-Q) and psychological readiness [self-efficacy (ESES…

medicine.medical_specialtyPhysical activityDiseases of the circulatory (Cardiovascular) systemMedicineHumansIn patientSjukgymnastikPhysiotherapyExerciseDepression (differential diagnoses)Heart failure; Depression; Physical activity; Readiness; Motivation; Self-efficacyNew York Heart Association Class ISelf-efficacyHeart FailureMotivationbusiness.industryDepressionPhysical activityDepression Heart failure Motivation Physical activity Readiness Self-efficacyOriginal Articlesmedicine.diseaseReadinessPhysical limitationsCross-Sectional StudiesRC666-701Mental stateHeart failurePhysical therapyOriginal ArticleSelf ReportCardiology and Cardiovascular MedicinebusinessSelf‐efficacyESC heart failure
researchProduct

Association Between Fatigue and Cognitive Impairment at 6 Months in Patients With Ischemic Stroke Treated With Acute Revascularization Therapy.

2019

Background: Fatigue is a frequent symptom after stroke. We aimed to determine the association between fatigue and cognitive performance in patients with ischemic stroke who received acute revascularization therapy (IV thrombolysis and/or mechanical thrombectomy).Methods: Seventy patients were prospectively included in the stroke unit of the University Hospital of Dijon, France. A follow-up was performed at 6 months with clinical examination, fatigue assessment by the Fatigue Severity Scale (FSS), and a comprehensive neuropsychological evaluation. Patients with fatigue (FSS score >4) were compared with patients without fatigue. Neuropsychological factors associated with fatigue at 6 month…

medicine.medical_specialtyPhysical examinationlcsh:RC346-42903 medical and health sciences0302 clinical medicineQuality of lifeInternal medicineischemic strokeMedicineMemory impairment030212 general & internal medicineCognitive rehabilitation therapyEffects of sleep deprivation on cognitive performanceStrokelcsh:Neurology. Diseases of the nervous systemDepression (differential diagnoses)Original Researchcognitive impairmentmedicine.diagnostic_testbusiness.industrymedicine.diseasestrokeNeurologydepressionoutcomefatigueNeurology (clinical)business030217 neurology & neurosurgeryExecutive dysfunctionFrontiers in neurology
researchProduct

Vestibular dysfunction in major depression

2007

medicine.medical_specialtyPhysical medicine and rehabilitationbusiness.industryGeneral NeurosciencemedicineVestibular dysfunctionbusinessDepression (differential diagnoses)Neuroscience
researchProduct

Anxiety, depression, chronic inflammation and aortic stiffness in Crohn's disease: the brain--gut--vascular axis.

2020

Background Patients with Crohn's disease have an increased aortic stiffness, a known cardiovascular risk factor. Anxiety, a key factor of the brain--gut axis in patients with Crohn's disease, is implicated in the pathogenesis and progression of the disease, and is linked with aortic stiffening in other clinical settings. Objectives Considering that depression is frequently linked to anxiety in Crohn's disease, we performed a mediation analysis to reveal the potential link between anxiety, depression and aortic stiffness in these patients. Methods Multicentre observational cross-sectional study of 86 consecutive patients with Crohn's disease and 86 matched control individuals. The connection…

medicine.medical_specialtyPhysiologypulse wave velocityDisease030204 cardiovascular system & hematologyAnxietyInflammatory bowel diseaseInflammatory bowel disease03 medical and health sciences0302 clinical medicineVascular StiffnessCrohn DiseaseInternal medicineInternal MedicineMedicineHumans030212 general & internal medicineRisk factorPulse wave velocityDepression (differential diagnoses)Aortaarterial stiffness inflammation inflammatory bowel disease pulse wave velocityInflammationCrohn's diseasebusiness.industryDepressionPulse wave velocity.medicine.diseaseGastrointestinal MicrobiomeArterial stiffnearterial stiffnessCross-Sectional StudiesArterial stiffnessCardiologyAnxietymedicine.symptomCardiology and Cardiovascular MedicinebusinessJournal of hypertension
researchProduct

Escitalopram for the prevention of peginterferon-alpha2a-associated depression in hepatitis C virus-infected patients without previous psychiatric di…

2012

BACKGROUND: Depression is a major complication during treatment of chronic hepatitis C virus (HCV) infection with interferon-alpha (IFN-alpha). It is unclear whether antidepressants can prevent IFN-induced depression in patients without psychiatric risk factors. OBJECTIVE: To examine whether preemptive antidepressant treatment with escitalopram can decrease the incidence or severity of depression associated with pegylated IFN-alpha in HCV-infected patients without a history of psychiatric disorders. DESIGN: Randomized, multicenter, double-blind, prospective, placebo-controlled, parallel-group trial. (ClinicalTrials.gov registration number: NCT00136318) SETTING: 10 university and 11 academic…

medicine.medical_specialtyPlacebolaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicineInternal MedicinemedicineEscitalopram030212 general & internal medicinePsychiatryDepression (differential diagnoses)business.industryIncidence (epidemiology)Absolute risk reductionGeneral MedicineHepatitis Cmedicine.disease3. Good healthTolerability030211 gastroenterology & hepatologybusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologymedicine.drug
researchProduct

Acetyl-L-Carnitine Supplementation and the Treatment of Depressive Symptoms: A Systematic Review and Meta-Analysis.

2017

Objective: Deficiency of acetyl-l-carnitine (ALC) seems to play a role in the risk of developing depression, indicating a dysregulation of fatty acid transport across the inner membrane of mitochondria. However, data about ALC supplementation in humans are limited. We thus conducted a systematic review and meta-analysis investigating the effect of ALC on depressive symptoms across randomized controlled trials (RCTs). Methods: A literature search in major databases, without language restriction, was undertaken from inception until 30 December 2016. Eligible studies were RCTs of ALC alone or in combination with antidepressant medications, with a control group taking placebo/no intervention or…

medicine.medical_specialtyPlacebonot knownlaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicineMedicineHumansAdverse effectApplied PsychologyDepression (differential diagnoses)Randomized Controlled Trials as Topicbusiness.industryDepressionIncidence (epidemiology)Confidence intervalAntidepressive Agents030227 psychiatryPsychiatry and Mental healthMeta-analysisDietary SupplementsVitamin B ComplexAntidepressantbusinessAcetylcarnitine030217 neurology & neurosurgeryPsychosomatic medicine
researchProduct

A systematic review of neuropsychiatric symptoms in mild cognitive impairment.

2009

Mild cognitive impairment (MCI) is a clinical concept proposed as an intermediate state between normal aging and dementia. This condition has multiple heterogeneous sources, including clinical presentation, etiology, and prognosis. Recently, the prevalence and associated features of neuropsychiatric symptoms (NPS) in MCI have been described. We systematically searched the PubMed database (last accessed on August 31, 2008) for articles on NPS in MCI. Included articles used strict selection criteria, and outcome variables were extracted in duplicate; of the 27 articles included, 14 (52%) used prospective cohorts. The global prevalence of NPS in MCI ranged from 35% to 85%. The most common beha…

medicine.medical_specialtyPopulationDiseaseNeuropsychological TestsIrritabilitybehavioral disciplines and activitiesAlzheimer DiseaseRisk FactorsInternal medicinemental disordersmedicineDementiaAlzheimer’s disease behavior dementia depression incidence mild cognitive impairment neuropsychiatric symptoms predictors prevalence risk factorsHumansProspective cohort studyeducationDepression (differential diagnoses)education.field_of_studyClinical Trials as TopicGeneral NeuroscienceMental DisordersGeneral Medicinemedicine.diseasePsychiatry and Mental healthClinical PsychologyEtiologyAnxietySettore MED/26 - NeurologiaGeriatrics and Gerontologymedicine.symptomPsychologyCognition DisordersClinical psychologyJournal of Alzheimer's disease : JAD
researchProduct